Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 3/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9066436 | 0.95 | EPHX2 (0.49) | EPHX2DGKANAAAHTR2CMAPT | |
| SCHEMBL634781 | 0.90 | EPHX2 (0.43) | EPHX2TSHR | |
| SCHEMBL5709873 | 0.83 | TSHR (0.47) | EPHX2NAAAMAPTMAPK1NPSR1 | |
| SCHEMBL30304082 | 0.83 | NAAA (0.46) | NAAAHTR2CMAPTMAPK1NPSR1 | |
| SCHEMBL30304015 | 0.83 | NAAA (0.46) | NAAAHTR2CMAPTMAPK1NPSR1 | |
| SCHEMBL15287645 | 0.83 | NAAA (0.46) | NAAAHTR2CMAPTMAPK1NPSR1 | |
| SCHEMBL11576818 | 0.81 | NAAA (0.52) | EPHX2DGKANAAAMAPTTSHR | |
| SCHEMBL9847336 | 0.81 | TSHR (0.45) | EPHX2NAAAMAPTMAPK1NPSR1 | |
| SCHEMBL8084596 | 0.80 | TSHR (0.57) | EPHX2NAAANPSR1TSHR | |
| SCHEMBL11576811 | 0.79 | TSHR (0.48) | EPHX2NAAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109795-A1 | HIGH REFRACTIVE INDEX POLYVINYL ACETAL RESINS MODIFIED WITH CYCLIC ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2026-04-23 | — | — | US | claimed |
| US-20260022224-A1 | METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | SOLUTIA INC. (US) | 2026-01-22 | — | — | US | claimed |
| EP-4676704-A1 | A METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS AS WELL AS POLY(VINYL BUTYRAL) SHEETS AND LAMINATED GLASS | Solutia Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4598999-A1 | HIGH REFRACTIVE INDEX POLYVINYL ACETAL RESINS MODIFIED WITH CYCLIC ALDEHYDES | Eastman Chemical Company (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4547460-A1 | METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | Solutia Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2024191649-A1 | A METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS AS WELL AS POLY(VINYL BUTYRAL) SHEETS AND LAMINATED GLASS | SOLUTIA INC. (US) | 2024-09-19 | — | — | WO | claimed |
| WO-2024076953-A1 | HIGH REFRACTIVE INDEX POLYVINYL ACETAL RESINS MODIFIED WITH CYCLIC ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2024-04-11 | — | — | WO | claimed |
| US-20240058994-A1 | A METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | SOLUTIA INC. (US) | 2024-02-22 | — | — | US | claimed |
| WO-2024006630-A1 | METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | SOLUTIA INC. (US) | 2024-01-04 | — | — | WO | claimed |
| EP-4274721-A1 | A METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | Solutia Inc. (US) | 2023-11-15 | — | — | EP | claimed |
| WO-2004108804-A1 | FLUORINATED POLYMER SHEETS | SOLUTIA INCORPORATED (US) | 2004-12-16 | — | — | WO | claimed |
| US-20040247883-A1 | Fluorinated polymer sheets | SOLUTIA INC. | 2004-12-09 | — | — | US | claimed |
| US-20040247893-A1 | Polyvinyl butyral sheet with bifunctional surface modifying agent | SOLUTIA INCORPORATED (US) | 2004-12-09 | — | — | US | claimed |
| US-6825255-B2 | ENHANCED WITH FATTY AMIDE AND PLASTICIZERS; LESS HAZE; ADHESION | SOLUTIA INCORPORATED | 2004-11-30 | — | — | US | claimed |
| WO-2004099304-A2 | POLYVINYL BUTYRAL SHEET HAVING ANTIBLOCKING CHARACTERISTICS | SOLUTIA INCORPORATED (US) | 2004-11-18 | — | — | WO | claimed |
| US-20040219365-A1 | ENHANCED WITH FATTY AMIDE AND PLASTICIZERS; LESS HAZE; ADHESION | SOLUTIA INCORPORATED | 2004-11-04 | — | — | US | claimed |
| EP-0938519-B1 | CONTROL OF ADHESION OF POLYVINYL BUTYRAL SHEET TO GLASS | SOLUTIA INC (US) | 2001-07-11 | — | — | EP | claimed |
| EP-0938519-A1 | CONTROL OF ADHESION OF POLYVINYL BUTYRAL SHEET TO GLASS | Solutia Inc. (US) | 1999-09-01 | — | — | EP | claimed |
| WO-1998021269-A1 | CONTROL OF ADHESION OF POLYVINYL BUTYRAL SHEET TO GLASS | SOLUTIA, INC. (US) | 1998-05-22 | — | — | WO | claimed |
| US-5728472-A | CONTAINING MULTIVALENT METAL-SUBSTITUTED AROMATIC CHELATE COMPOUND | MONSANTO COMPANY (US) | 1998-03-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022224-A1 | METHOD OF RECYCLING POLY(VINYL BUTYRAL) FROM MULTILAYER POLY(VINYL BUTYRAL) SHEETS | PCBP1, VCL, PHB2 | EPHX2 4232/4885DGKA 3015/4885NAAA 4736/4885 |
| US-20260109795-A1 | HIGH REFRACTIVE INDEX POLYVINYL ACETAL RESINS MODIFIED WITH CYCLIC ALDEHYDES | TRIM4, TRIM58, TRA2B | EPHX2 2691/4885DGKA 3319/4885NAAA 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.